Phenohytro NDC 17856-0125

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-0125Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-0125Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
17856-0125-1	17856012501	72 CUP, UNIT-DOSE in 1 BOX (17856-0125-1) / 10 mL in 1 CUP, UNIT-DOSE (17856-0125-3)Marketed from Apr 8, 2024
17856-0125-2	17856012502	72 CUP, UNIT-DOSE in 1 BOX (17856-0125-2) / 5 mL in 1 CUP, UNIT-DOSE (17856-0125-4)Marketed from Apr 8, 2024
17856-0125-5	17856012505	45 SYRINGE in 1 CASE (17856-0125-5) / 5 mL in 1 SYRINGEMarketed from May 19, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenohytro
Generic name (nonproprietary): phenobarbital, hyoscyamine sulfate, atropine sulfate, and scopolamine hydrobromide
Active ingredients: Phenobarbital — 16.2 mg/5mLHyoscyamine sulfate — .1037 mg/5mLAtropine sulfate — .0194 mg/5mLScopolamine hydrobromide — .0065 mg/5mL
Dosage form: Elixir
Route: Oral
Labeler: ATLANTIC BIOLOGICALS CORP.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Aug 30, 2018
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Cholinergic Antagonists (Mechanism)Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 17856-0125_5230a82a-5a35-c03e-e063-6294a90aa754SPL ID 5230a82a-5a35-c03e-e063-6294a90aa754SPL set ID a5aaf1db-1938-4073-9da4-c47f959d013eRxCUI 1046787, 2048017UNII YQE403BP4D, F2R8V82B84, 03J5ZE7KA5, 451IFR0GXB
Pharmacologic class: Anticholinergic; Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856012501 followed by a unit qualifier and the quantity

Package 17856-0125-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 19, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Based on the National Academy of Sciences-National Research Council's review of this drug and/or other information, FDA has classified the following indications as "possibly" effective: For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. May also be useful as adjunctive therapy in the treatment of duodenal ulcer. IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC / ANTISPASMODIC DRUGS AID IN THE HEALING OF A DUODENAL ULCER, DECREASE THE RATE OF RECURRENCES, OR PREVENT COMPLICATIONS.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)